Multiple Sclerosis, Relapsing-Remitting research hub
4 indexed studies · 1 currently recruiting
- active not recruitingPHASE4
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
This study looks at whether treating relapsing-remitting MS early with strong medication is better than starting with milder treatments and stepping up later. It aims to help patients and doctors decide the best way to manage MS from the start.
United States · United Kingdom - active not recruitingPHASE3
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
This study is testing a new tablet, IMU-838, for people aged 18-55 with a type of multiple sclerosis (MS) called relapsing MS. It wants to see how well it works, if it's safe, and if people can tolerate it compared to a dummy tablet.
United States · Armenia · Bosnia and Herzegovina - active not recruitingPHASE3
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
This study looks at a new drug, BIIB017, for children and teenagers with a type of multiple sclerosis (MS) called relapsing-remitting MS. It checks if the drug is safe, well-tolerated, and how well it works over time. Researchers are also studying how the body handles the drug.
United States · Argentina · Australia - recruiting
Biomarkers of aHSCT
This study looks at how a stem cell transplant (aHSCT) works for multiple sclerosis (MS) and other immune-related brain conditions. Researchers want to understand why it helps some people more than others and find ways to predict its success or failure.
United Kingdom